Airton Leonardo de Oliveira Manoel1,2,3,4, Ann Mansur5,6, Gisele Sampaio Silva7,8, Menno R Germans9, Blessing N R Jaja5, Ekaterina Kouzmina10, Thomas R Marotta10,5, Simon Abrahamson11,12, Tom A Schweizer5, Julian Spears5,13, R Loch Macdonald5,13. 1. Department of Medical Imaging, Interventional Neuroradiology, St. Michael's Hospital, University of Toronto, 3-141 CC, St. Michael's Hospital, 30 Bond Street, Toronto, ON, M5B 1W8, Canada. airtonleo.manoel@gmail.com. 2. Department of Critical Care Medicine, Trauma and Neurosurgical Intensive Care Unit, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. airtonleo.manoel@gmail.com. 3. Neuroscience Research Program, Keenan Research Centre for Biomedical Science of St. Michael's Hospital, Toronto, Canada. airtonleo.manoel@gmail.com. 4. Neurology and Neurosurgery Department, Universidade Federal de São Paulo, São Paulo, Brazil. airtonleo.manoel@gmail.com. 5. Neuroscience Research Program, Keenan Research Centre for Biomedical Science of St. Michael's Hospital, Toronto, Canada. 6. Faculty of Medicine, University of Toronto, Toronto, Canada. 7. Neurology and Neurosurgery Department, Universidade Federal de São Paulo, São Paulo, Brazil. 8. Instituto Israelita de Pesquisa Albert Einstein, Neurology Program, São Paulo, Brazil. 9. Department of Neurosurgery, Radboud University Medical Center, Nijmegen, The Netherlands. 10. Department of Medical Imaging, Interventional Neuroradiology, St. Michael's Hospital, University of Toronto, 3-141 CC, St. Michael's Hospital, 30 Bond Street, Toronto, ON, M5B 1W8, Canada. 11. Department of Critical Care Medicine, Trauma and Neurosurgical Intensive Care Unit, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. 12. Department of Anesthesiology, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. 13. Division of Neurosurgery, Department of Surgery, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
Abstract
BACKGROUND AND PURPOSE: Poor-grade subarachnoid hemorrhage (SAH) (World Federation of Neurosurgical Societies grade 4 and 5) is associated with high mortality rates and unfavorable functional outcomes. We report a single-center cohort of poor-grade SAH patients, combined with a systematic review of studies reporting functional outcome in the poor-grade SAH population. METHODS: Data on a cohort of poor-grade SAH patients treated between 2009 and 2013 were retrospectively collected and combined with a systematic review (from inception to November 2015; PubMed, Embase). Two reviewers assessed the studies independently based on predefined inclusion criteria: consecutive poor-grade SAH, functional outcome measured at least 3 months after hemorrhage, and the report of patients who died before aneurysm treatment. RESULTS: The search yielded 329 publications, and 23 met our inclusion criteria with 2713 subjects enrolled from 1977 to 2014 in 10 countries (including 179 poor-grade patients from our cohort). Mortality rate was 60 % (1683 patients), of which 806 (29 %) died before and 877 (31 %) died after aneurysm treatment, respectively. Treatment was undertaken in 1775 patients (1775/2826-63 %): 1347 by surgical clipping (1347/1775-76 %) and 428 (428/1775-24 %) by endovascular methods. Outcome was favorable in 794 patients (28 %) and unfavorable in 1867 (66 %). When the studies were grouped into decades, favorable outcome increased from 13 % in the late 1970s to early 1980s to 35 % in the late 1980s to early 1990s, and remained unchanged thereafter. CONCLUSION: Although mortality remains high in poor-grade SAH patients, a favorable functional outcome can be achieved in approximately one-third of patients. The development of new diagnostic methods and implementation of therapeutic approaches were probably responsible for the decrease in mortality and improvement in the functional outcome from 1970 to the 1990s. The plateau in functional outcome seen thereafter might be explained by the treatment of sicker and older patients and by the lack of new therapeutic interventions specific for SAH.
BACKGROUND AND PURPOSE: Poor-grade subarachnoid hemorrhage (SAH) (World Federation of Neurosurgical Societies grade 4 and 5) is associated with high mortality rates and unfavorable functional outcomes. We report a single-center cohort of poor-grade SAHpatients, combined with a systematic review of studies reporting functional outcome in the poor-grade SAH population. METHODS: Data on a cohort of poor-grade SAHpatients treated between 2009 and 2013 were retrospectively collected and combined with a systematic review (from inception to November 2015; PubMed, Embase). Two reviewers assessed the studies independently based on predefined inclusion criteria: consecutive poor-grade SAH, functional outcome measured at least 3 months after hemorrhage, and the report of patients who died before aneurysm treatment. RESULTS: The search yielded 329 publications, and 23 met our inclusion criteria with 2713 subjects enrolled from 1977 to 2014 in 10 countries (including 179 poor-grade patients from our cohort). Mortality rate was 60 % (1683 patients), of which 806 (29 %) died before and 877 (31 %) died after aneurysm treatment, respectively. Treatment was undertaken in 1775 patients (1775/2826-63 %): 1347 by surgical clipping (1347/1775-76 %) and 428 (428/1775-24 %) by endovascular methods. Outcome was favorable in 794 patients (28 %) and unfavorable in 1867 (66 %). When the studies were grouped into decades, favorable outcome increased from 13 % in the late 1970s to early 1980s to 35 % in the late 1980s to early 1990s, and remained unchanged thereafter. CONCLUSION: Although mortality remains high in poor-grade SAHpatients, a favorable functional outcome can be achieved in approximately one-third of patients. The development of new diagnostic methods and implementation of therapeutic approaches were probably responsible for the decrease in mortality and improvement in the functional outcome from 1970 to the 1990s. The plateau in functional outcome seen thereafter might be explained by the treatment of sicker and older patients and by the lack of new therapeutic interventions specific for SAH.
Authors: Airton Leonardo de Oliveira Manoel; David Turkel-Parrella; Abhijit Duggal; Amanda Murphy; Victoria McCredie; Thomas R Marotta Journal: Cleve Clin J Med Date: 2015-03 Impact factor: 2.321
Authors: Simone C Oudshoorn; Gabriel J E Rinkel; Andrew J Molyneux; Richard S Kerr; Sanne M Dorhout Mees; Daan Backes; Ale Algra; Mervyn D I Vergouwen Journal: Neurocrit Care Date: 2014-08 Impact factor: 3.210
Authors: E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa Journal: Stroke Date: 2012-05-03 Impact factor: 7.914
Authors: Christian Fung; Fabienne Inglin; Michael Murek; Mathias Balmer; Janine Abu-Isa; Werner J Z'Graggen; Christoph Ozdoba; Jan Gralla; Stephan M Jakob; Jukka Takala; Jürgen Beck; Andreas Raabe Journal: J Neurosurg Date: 2015-09-18 Impact factor: 5.115
Authors: DeWitte T Cross; David L Tirschwell; Mary Ann Clark; Dan Tuden; Colin P Derdeyn; Christopher J Moran; Ralph G Dacey Journal: J Neurosurg Date: 2003-11 Impact factor: 5.115
Authors: Airton Leonardo de Oliveira Manoel; Ann Mansur; Amanda Murphy; David Turkel-Parrella; Matt Macdonald; R Loch Macdonald; Walter Montanera; Thomas R Marotta; Aditya Bharatha; Khaled Effendi; Tom A Schweizer Journal: Crit Care Date: 2014-11-13 Impact factor: 9.097
Authors: Martin Kieninger; Julia Flessa; Nicole Lindenberg; Sylvia Bele; Andreas Redel; André Schneiker; Gerhard Schuierer; Christina Wendl; Bernhard Graf; Vera Silbereisen Journal: Neurocrit Care Date: 2018-02 Impact factor: 3.210
Authors: Bartosz Sokół; Norbert Wąsik; Roman Jankowski; Marcin Hołysz; Witold Mańko; Robert Juszkat; Tomasz Małkiewicz; Paweł P Jagodziński Journal: Biomed Res Int Date: 2017-05-29 Impact factor: 3.411
Authors: Olli-Pekka Kämäräinen; Jukka Huttunen; Antti Lindgren; Maarit Lång; Stepani Bendel; Ari Uusaro; Ilkka Parviainen; Timo Koivisto; Helena Isoniemi; Juha E Jääskeläinen Journal: Acta Neurochir (Wien) Date: 2018-06-27 Impact factor: 2.216
Authors: Airton Leonardo de Oliveira Manoel; Mathieu van der Jagt; Sepideh Amin-Hanjani; Nicholas C Bambakidis; Gretchen M Brophy; Ketan Bulsara; Jan Claassen; E Sander Connolly; S Alan Hoffer; Brian L Hoh; Robert G Holloway; Adam G Kelly; Stephan A Mayer; Peter Nakaji; Alejandro A Rabinstein; Peter Vajkoczy; Mervyn D I Vergouwen; Henry Woo; Gregory J Zipfel; Jose I Suarez Journal: Neurocrit Care Date: 2019-06 Impact factor: 3.210
Authors: Sean N Neifert; Emily K Chapman; Michael L Martini; William H Shuman; Alexander J Schupper; Eric K Oermann; J Mocco; R Loch Macdonald Journal: Transl Stroke Res Date: 2020-10-19 Impact factor: 6.829